Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection.
about
Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringImaging metabolic heterogeneity in cancerImaging tumor metabolism using positron emission tomographyA novel (11)C-labeled thymidine analog, [(11)C]AZT, for tumor imaging by positron emission tomography.Radiopharmaceuticals as probes to characterize tumour tissue.Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.Depicting changes in tumor biology in response to cetuximab mono- or combination therapy by apoptosis and proliferation imaging using 18F-ICMT-11 and 3'-Deoxy-3'-[18F]Fluorothymidine (18F-FLT) PET.
P2860
Q26765882-97A7E741-2140-41AC-8A6E-76681FF7C28EQ28076500-D8D625D0-2DFC-4E7C-8D46-F44FA55C9BEEQ28085278-80FB60BE-8BEA-4960-B0FF-CB53730BE8C6Q36134948-C3A4E66A-C4FD-4825-B4B8-42BB790AB9BEQ38342458-5781E211-1D16-4F9A-9BE3-E00DC446488AQ38547110-87F6FEED-2A8C-4E8E-96E2-53661C2CFEF7Q54978369-A4739A45-7CB4-41D1-B2C5-9C9DA48BD516
P2860
Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Preclinical evaluation of 3-18 ...... ing agent for tumor detection.
@en
type
label
Preclinical evaluation of 3-18 ...... ing agent for tumor detection.
@en
prefLabel
Preclinical evaluation of 3-18 ...... ing agent for tumor detection.
@en
P2093
P50
P1476
Preclinical evaluation of 3-18 ...... ing agent for tumor detection.
@en
P2093
Diana Brickute
Frazer Twyman
Israt S Alam
Maciej Kaliszczak
Quang-Dé Nguyen
Sebastian Trousil
P304
P356
10.2967/JNUMED.114.140343
P407
P577
2014-07-10T00:00:00Z